Objective: to observe the condition of blood rheology and the change of blood-f at in the patients with coronary heart disease of phlegm-stagnancy-type compared with those without phlegm stagnancy.

Relationship between Phlegm-Stasis Syndrome and Metabolic Syndrome in Patients with Non-alcoholic Fatty Liver Dieases;

Objective: To study the proportion of phlegm-stasis syndrome in complex diseases and to explore its relations to Prethrombotic State.

To observe the lipid-regulating effect of TIAOZHITONGMAI granule directed by method qi supplement and blood activation combined with phlegm transformation treatment method on the patients with the phlegm-blood-stasis syndrome of hyperlipidemia.

Objective:To evaluate the lipid- regulating effect,the safety of the Hawthorn Jiangzhi pill and the clinical efficacy for some patients with the coronary heart disease or the high blood pressure patients,through the clinical observation of the treatment of the patients with the phlegm-blood-stasis syndrome of hyperlipidemia with Hawthorn Jiangzhi pill.

Objective: To study the relationship between Phlegm-blood stasis syndrome and inflammation in patients with acute coronary syndrome.

Conclusion: The phlegm-blood stasis syndrome has the similar pathomechanism in these two kinds of diseases,which offers evidence for the theory of the same syndr.

Objective Through a great amount documents retrospecting in this research, We found that, most of the studies about the reasons and mechanisms of the formation of CAD marked by phlegm-blood stasis syndrome, focus on the abnormity of lipoprotein and hemorheology, but few on immunity or inflammation.